Mineralys Therapeutics, Inc.
MLYS· Nasdaq
Mineralys Therapeutics, Inc.
- Last sale
- Oct 1, 2026 · -5.55%
- Market cap
- $2.10B
- 88.41M shares
- Filings
- 399
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $132,009,000 | reported | |
| FY 2024 | 2024-12-31 | $168,581,000 | reported | |
| FY 2023 | 2023-12-31 | $70,361,000 | reported | |
| FY 2022 | 2022-12-31 | $26,250,000 | reported |
Mineralys Therapeutics, Inc. · CIK 1933414 · Engraved from SEC EDGAR
